未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 分享 收藏 Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older: Multicenter study阿特珠单抗联合贝伐单抗与来伐替尼治疗80岁及以上肝癌患者的疗效比较: 多中心研究
Hatanaka, Takeshi; Kakizaki, Satoru; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Yokohama, Keisuke; Nishikawa, Hiroki; Nishimura, Takashi; Shimada, Noritomo; Kawata, Kazuhito; Kosaka, Hisashi; Naganuma, Atsushi; Yata, Yutaka; Ohama, Hideko; Kuroda, Hidekatsu; Aoki, Tomoko; Tanaka, Kazunari; Tanaka, Takaaki; Tada, Fujimasa; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Koizumi, Yohei; Nakamura, Shinichiro; Kaibori, Masaki; Iijima, Hiroko; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi 分享 收藏 Clinical role of radiofrequency ablation for early-stage hepatocellular carcinoma in an advanced aging societyOchi, Hironori; Hiraoka, Atsushi; Tanaka, Takaaki; Mashiba, Toshie; Ohama, Hideko; Tada, Fujimasa; Fang, Cao; Shimamoto, Toyoki; Amano, Michiko; Azemoto, Nobuaki; Hirooka, Masashi; Yokota, Tomoyuki; Hiasa, Yoichi 分享 收藏 Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis阿特珠单抗联合贝伐单抗与来伐替尼或索拉非尼在非病毒性不可切除肝细胞癌中的比较: 一项国际倾向评分匹配分析Rimini, M.; Rimassa, L.; Ueshima, K.; Burgio, V; Shigeo, S.; Tada, T.; Suda, G.; Yoo, C.; Cheon, J.; Pinato, D. J.; Lonardi, S.; Scartozzi, M.; Iavarone, M.; Di Costanzo, G. G.; Marra, F.; Solda, C.; Tamburini, E.; Piscaglia, F.; Masi, G.; Cabibbo, G.; Foschi, F. G.; Silletta, M.; Pressiani, T.; Nishida, N.; Iwamoto, H.; Sakamoto, N.; Ryoo, B-Y; Chon, H. J.; Claudia, F.; Niizeki, T.; Sho, T.; Kang, B.; D'Alessio, A.; Kumada, T.; Hiraoka, A.; Hirooka, M.; Kariyama, K.; Tani, J.; Atsukawa, M.; Takaguchi, K.; Itobayashi, E.; Fukunishi, S.; Tsuji, K.; Ishikawa, T.; Tajiri, K.; Ochi, H.; Yasuda, S.; Toyoda, H.; Ogawa, C.; Nishimur, T.; Hatanaka, T.; Kakizaki, S.; Shimada, N.; Kawata, K.; Tanaka, T.; Ohama, H.; Nouso, K.; Morishita, A.; Tsutsui, A.; Nagano, T.; Itokawa, N.; Okubo, T.; Arai, T.; Imai, M.; Naganuma, A.; Koizumi, Y.; Nakamura, S.; Joko, K.; Iijima, H.; Hiasa, Y.; Pedica, F.; De Cobelli, F.; Ratti, F.; Alrighetti, L.; Kudo, M.; Cascinu, S.; Casadei-Gardini, A. 分享 收藏 Deterioration of liver function and aging disturb sequential systemic therapy for unresectable hepatocellular carcinomaShimose, Shigeo; Hiraoka, Atsushi; Tanaka, Masatoshi; Iwamoto, Hideki; Tanaka, Takaaki; Noguchi, Kazunori; Aino, Hajime; Yamaguchi, Taizo; Itano, Satoshi; Suga, Hideya; Niizeki, Takashi; Moriyama, Etsuko; Shirono, Tomotake; Noda, Yu; Kamachi, Naoki; Okamura, Shusuke; Nakano, Masahito; Kawaguchi, Takumi; Kuromatsu, Ryoko; Koga, Hironori; Torimura, Takuji 分享 收藏 Development and validation of a modified albumin-bilirubin grade and α-fetoprotein score (mALF score) for hepatocellular carcinoma patients receiving atezolizumab and bevacizumab开发和验证接受阿特珠单抗和贝伐单抗的肝细胞癌患者的改良白蛋白-胆红素等级和甲胎蛋白评分 (mALF评分)Hatanaka, Takeshi; Kakizaki, Satoru; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Shimada, Noritomo; Kawata, Kazuhito; Kosaka, Hisashi; Tanaka, Takaaki; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Naganuma, Atsushi; Koizumi, Yohei; Nakamura, Shinichiro; Kaibori, Masaki; Iijima, Hiroko; Hiasa, Yoichi; Kumada, Takashi 分享 收藏 Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective studyC反应蛋白和甲胎蛋白对接受阿特珠单抗联合贝伐单抗治疗的肝细胞癌患者免疫治疗评分的预后影响: 一项多中心回顾性研究Hatanaka, Takeshi; Kakizaki, Satoru; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Shimada, Noritomo; Kawata, Kazuhito; Kosaka, Hisashi; Tanaka, Takaaki; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Naganuma, Atsushi; Koizumi, Yohei; Nakamura, Shinichiro; Joko, Kouji; Kaibori, Masaki; Iijima, Hiroko; Hiasa, Yoichi; Kumada, Takashi 分享 收藏 Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child-Pugh class A or B liver function in real-world clinical practice在真实世界临床实践中，阿特珠单抗联合贝伐珠单抗治疗Child-Pugh A级或B级肝功能的不可切除性肝细胞癌的疗效研究Tanaka, Takaaki; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Naganuma, Atsushi; Kosaka, Hisashi; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Koizumi, Yohei; Nakamura, Shinichiro; Joko, Kouji; Iijima, Hiroko; Kaibori, Masaki; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi 分享 收藏 C-reactive protein to albumin ratio predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinibTada, Toshifumi; Kumada, Takashi; Hiraoka, Atsushi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Tanaka, Takaaki; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Naganuma, Atsushi; Aoki, Tomoko; Koizumi, Yohei; Nakamura, Shinichiro; Joko, Kouji; Hiasa, Yoichi; Kudo, Masatoshi 分享 收藏 Association of early bevacizumab interruption with efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: A landmark analysisHatanaka, Takeshi; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Tanaka, Takaaki; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Naganuma, Atsushi; Koizumi, Yohei; Nakamura, Shinichiro; Joko, Kouji; Iijima, Hiroko; Hiasa, Yoichi; Kumada, Takashi 分享 收藏 Early experience of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma BCLC-B stage patients classified as beyond up to seven criteria - Multicenter analysisHiraoka, Atsushi; Kumada, Takashi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Naganuma, Atsushi; Tanaka, Takaaki; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Koizumi, Yohei; Nakamura, Shinichiro; Joko, Kouji; Iijima, Hiroko; Hiasa, Yoichi; Kudo, Masatoshi 分享 收藏 Measurement of multiple spleen lengths is not necessary for non-invasive prediction of high-risk esophagogastric varices测量多个脾脏长度对于高危食管胃静脉曲张的无创预测是不必要的Hirooka, Masashi; Tanaka, Takaaki; Koizumi, Yohei; Yano, Ryo; Sunago, Kotarou; Watanabe, Takao; Yoshida, Osamu; Tokumoto, Yoshio; Abe, Masanori; Hiasa, Yoichi 分享 收藏 Efficacy of lenvatinib for unresectable hepatocellular carcinoma based on background liver disease etiology: multi-center retrospective studyHiraoka, Atsushi; Kumada, Takashi; Tada, Toshifumi; Tani, Joji; Kariyama, Kazuya; Fukunishi, Shinya; Atsukawa, Masanori; Hirooka, Masashi; Tsuji, Kunihiko; Ishikawa, Toru; Takaguchi, Koichi; Itobayashi, Ei; Tajiri, Kazuto; Shimada, Noritomo; Shibata, Hiroshi; Ochi, Hironori; Kawata, Kazuhito; Yasuda, Satoshi; Toyoda, Hidenori; Aoki, Tomoko; Tanaka, Takaaki; Ohama, Hideko; Nouso, Kazuhiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Arai, Taeang; Okubo, Tomomi; Imai, Michitaka; Koizumi, Yohei; Nakamura, Shinichiro; Joko, Koji; Hiasa, Yoichi; Kudo, Masatoshi 分享 收藏 Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib不良事件是lenvatinib治疗晚期肝细胞癌患者活动的潜在预测因素Rapposelli, Ilario Giovanni; Tada, Toshifumi; Shimose, Shigeo; Burgio, Valentina; Kumada, Takashi; Iwamoto, Hideki; Hiraoka, Atsushi; Niizeki, Takashi; Atsukawa, Masanori; Koga, Hironori; Hirooka, Masashi; Torimura, Takuji; Iavarone, Massimo; Tortora, Raffaella; Campani, Claudia; Lonardi, Sara; Tamburini, Emiliano; Piscaglia, Fabio; Masi, Gianluca; Cabibbo, Giuseppe; Giuseppe Foschi, Francesco; Silletta, Marianna; Tsuji, Kunihiko; Ishikawa, Toru; Takaguchi, Koichi; Kariyama, Kazuya; Itobayashi, Ei; Tajiri, Kazuto; Shimada, Noritomo; Shibata, Hiroshi; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Fukunishi, Shinya; Ohama, Hideko; Kawata, Kazuhito; Tani, Joji; Nakamura, Shinichiro; Nouso, Kazuhiro; Tsutsui, Akemi; Nagano, Takuya; Tanaka, Takaaki; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Joko, Kouji; Koizumi, Yohei; Hiasa, Yoichi; Rimini, Margherita; Ratti, Francesca; Aldrighetti, Luca; Cascinu, Stefano; Casadei-Gardini, Andrea 分享 收藏 Impact of modified albumin-bilirubin grade on survival in patients with HCC who received lenvatinibTada, Toshifumi; Kumada, Takashi; Hiraoka, Atsushi; Atsukawa, Masanori; Hirooka, Masashi; Tsuji, Kunihiko; Ishikawa, Toru; Takaguchi, Koichi; Kariyama, Kazuya; Itobayashi, Ei; Tajiri, Kazuto; Shimada, Noritomo; Shibata, Hiroshi; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Fukunishi, Shinya; Ohama, Hideko; Kawata, Kazuhito; Tani, Joji; Nakamura, Shinichiro; Nouso, Kazuhiro; Tsutsui, Akemi; Nagano, Takuya; Takaaki, Tanaka; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Joko, Kouji; Koizumi, Yohei; Hiasa, Yoichi 分享 收藏 The long noncoding RNA of RMRP is downregulated by PERK, which induces apoptosis in hepatocellular carcinoma cellsYukimoto, Atsushi; Watanabe, Takao; Sunago, Kotaro; Nakamura, Yoshiko; Tanaka, Takaaki; Koizumi, Yohei; Yoshida, Osamu; Tokumoto, Yoshio; Hirooka, Masashi; Abe, Masanori; Hiasa, Yoichi 分享 收藏 Radiofrequency Ablation Covering the Entire Tumor Blood Drainage Area Improves Survival in Hepatocellular CarcinomaHirooka, Masashi; Koizumi, Yohei; Tanaka, Takaaki; Sunago, Kotarou; Nakamura, Yoshiko; Watanabe, Takao; Yoshida, Osamu; Tokumoto, Yoshio; Abe, Masanori; Hiasa, Yoichi 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
